OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Michela Stucchi

1 Projects | 1 Researchers | $250,000 Invested

2011

Axxam SpA

Michela Stucchi, PhD

Small Molecule P2X7 Antagonists for AD Treatment

  • Funding Amount: $250,000
  • Organization Type: Biotechnology/For Profit
  • Program: Drug Discovery
  • Status: Closed